Literature DB >> 18516617

The effect of nitric oxide synthase and cyclooxygenase inhibition on cutaneous microvascular reactivity.

Helena Lenasi1, Martin Strucl.   

Abstract

The role of nitric oxide (NO)- and prostacyclin (PGI(2))-independent mechanism, potentially attributable to endothelium-derived hyperpolarizing factor (EDHF), has not been extensively studied in human skin microcirculation. The aim of our study was to elucidate the contribution of the NO- and PGI(2)-independent mechanism to microvascular reactivity of cutaneous microcirculation. Skin perfusion was measured on the volar aspect of the forearm in 12 healthy male subjects (mean age 25.0 +/- 1.5), using laser Doppler (LD) fluxmetry. Combined endothelial nitric oxide synthase (eNOS) and cyclooxygenase (COX) inhibition was achieved by an intradermal injection (10 microl) of the eNOS inhibitor, L(omega)-monomethyl L-arginine (L-NMMA, 10 mM) and the COX inhibitor, diclofenac (10 mM); saline was injected as a control. LD flux was assessed at rest and after an iontophoretical application of acetylcholine (ACh, 1%), an endothelial agonist and sodium nitroprusside (SNP, 1%), an endothelium-independent agonist, respectively. Combined eNOS and COX inhibition had no effect on the baseline LDF (12.5 +/- 2.3 PU (perfusion units) in control vs. 10.9 +/- 1.8 PU in the treated site). On the other hand, the ACh-stimulated increase in LDF was significantly attenuated after eNOS and COX inhibition (390.5 +/- 43.5%), compared to the control (643.7 +/- 80.3% increase, t-test, P < 0.05). Nevertheless, at least 60% of ACh-mediated vasodilatation was preserved after combined eNOS and COX inhibition. eNOS and COX inhibition had no impact on the SNP-stimulated increase in LDF (768.8 +/- 70.5% in control vs. 733.5 +/- 54.6% in the treated site). These findings indicate that NO- and PGI(2)-independent mechanism plays an important role in the regulation of blood flow in the human skin microcirculation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516617     DOI: 10.1007/s00421-008-0769-8

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  37 in total

1.  Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells.

Authors:  T Osanai; N Fujita; N Fujiwara; T Nakano; K Takahashi; W Guan; K Okumura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-01       Impact factor: 4.733

2.  Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients.

Authors:  S Taddei; L Ghiadoni; A Virdis; S Buralli; A Salvetti
Journal:  Circulation       Date:  1999-09-28       Impact factor: 29.690

3.  Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation.

Authors:  Martin Berghoff; Madeera Kathpal; Sonja Kilo; Max J Hilz; Roy Freeman
Journal:  J Appl Physiol (1985)       Date:  2002-02

4.  Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization.

Authors:  M L Honing; P Smits; P J Morrison; T J Rabelink
Journal:  Hypertension       Date:  2000-06       Impact factor: 10.190

5.  Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo.

Authors:  Y Nishikawa; D W Stepp; W M Chilian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-08       Impact factor: 4.733

6.  Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor.

Authors:  S D Katz; H Krum
Journal:  Am J Cardiol       Date:  2001-05-01       Impact factor: 2.778

7.  Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension.

Authors:  L Mantelli; S Amerini; F Ledda
Journal:  J Cardiovasc Pharmacol       Date:  1995-04       Impact factor: 3.105

8.  Acetylcholine-induced vasodilation and reactive hyperemia are not affected by acute cyclo-oxygenase inhibition in human skin.

Authors:  Anne Dalle-Ave; Sandrine Kubli; Sandrine Golay; Anne Delachaux; Lucas Liaudet; Bernard Waeber; François Feihl
Journal:  Microcirculation       Date:  2004-06       Impact factor: 2.628

9.  Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole.

Authors:  Jens Passauer; Eckhart Büssemaker; Grit Lässig; Frank Pistrosch; Joachim Fauler; Peter Gross; Ingrid Fleming
Journal:  Clin Sci (Lond)       Date:  2003-10       Impact factor: 6.124

10.  Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet.

Authors:  O A Sofola; A Knill; R Hainsworth; M Drinkhill
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

View more
  12 in total

Review 1.  Resting blood flow in the skin: does it exist, and what is the influence of temperature, aging, and diabetes?

Authors:  Jerrold Scott Petrofsky
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

2.  Cutaneous blood flow during intradermal NO administration in young and older adults: roles for calcium-activated potassium channels and cyclooxygenase?

Authors:  Naoto Fujii; Robert D Meade; Christopher T Minson; Vienna E Brunt; Pierre Boulay; Ronald J Sigal; Glen P Kenny
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-06       Impact factor: 3.619

3.  Acute exhaustive rowing exercise reduces skin microvascular dilator function in young adult rowing athletes.

Authors:  Marko Stupin; Ana Stupin; Lidija Rasic; Anita Cosic; Luka Kolar; Vatroslav Seric; Helena Lenasi; Kresimir Izakovic; Ines Drenjancevic
Journal:  Eur J Appl Physiol       Date:  2017-12-21       Impact factor: 3.078

4.  Progesterone enhances adrenergic control of skin blood flow in women with high but not low orthostatic tolerance.

Authors:  Megan M Wenner; Hugh S Taylor; Nina S Stachenfeld
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

Review 5.  Vascular pharmacology of epoxyeicosatrienoic acids.

Authors:  Sandra L Pfister; Kathryn M Gauthier; William B Campbell
Journal:  Adv Pharmacol       Date:  2010

6.  Low fingertip temperature rebound measured by digital thermal monitoring strongly correlates with the presence and extent of coronary artery disease diagnosed by 64-slice multi-detector computed tomography.

Authors:  Naser Ahmadi; Vahid Nabavi; Vivek Nuguri; Fereshteh Hajsadeghi; Ferdinand Flores; Mohammad Akhtar; Stanley Kleis; Harvey Hecht; Morteza Naghavi; Matthew Budoff
Journal:  Int J Cardiovasc Imaging       Date:  2009-07-26       Impact factor: 2.357

7.  Reduced arteriovenous shunting capacity after local heating and redistribution of baseline skin blood flow in type 2 diabetes assessed with velocity-resolved quantitative laser Doppler flowmetry.

Authors:  Ingemar Fredriksson; Marcus Larsson; Fredrik H Nyström; Toste Länne; Carl J Ostgren; Tomas Strömberg
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

8.  Impaired acetylcholine-induced cutaneous vasodilation in young smokers: roles of nitric oxide and prostanoids.

Authors:  Naoto Fujii; Maggie C Reinke; Vienna E Brunt; Christopher T Minson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-11       Impact factor: 4.733

9.  Association of coronary artery calcium score and vascular dysfunction in long-term hemodialysis patients.

Authors:  Irfan Zeb; Naser Ahmadi; Miklos Z Molnar; Dong Li; Ronney Shantouf; Parta Hatamizadeh; Taeyoung Choi; Kamyar Kalantar-Zadeh; Matthew J Budoff
Journal:  Hemodial Int       Date:  2012-09-11       Impact factor: 1.812

10.  Impaired skin microcirculation in paediatric patients with type 1 diabetes mellitus.

Authors:  Mirjam Heimhalt-El Hamriti; Corinna Schreiver; Anja Noerenberg; Julia Scheffler; Ulrike Jacoby; Dieter Haffner; Dagmar-C Fischer
Journal:  Cardiovasc Diabetol       Date:  2013-08-12       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.